Literature DB >> 26246256

Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship.

Marcelo B P Siqueira1, Anas Saleh1, Alison K Klika1, Colin O'Rourke1, Steven Schmitt1, Carlos A Higuera1, Wael K Barsoum1.   

Abstract

BACKGROUND: The clinical benefit of chronic suppression with oral antibiotics as a salvage treatment for periprosthetic joint infection is unclear. The purpose of this study was to compare infection-free prosthetic survival rates between patients who received chronic oral antibiotics and those who did not following irrigation and debridement with polyethylene exchange or two-stage revision for periprosthetic joint infection.
METHODS: We reviewed the records on all irrigation and debridement procedures with polyethylene exchange and two-stage revisions performed at our institution from 1996 to 2010 for hip or knee periprosthetic joint infection. Of 625 patients treated with a total of 655 eligible revisions, ninety-two received chronic oral antibiotics for a minimum of six months and were eligible for inclusion in our study. These patients were compared with a matched cohort (ratio of 1:3) who did not receive chronic oral antibiotics.
RESULTS: The five-year infection-free prosthetic survival rate was 68.5% (95% confidence interval [CI] = 59.2% to 79.3%) for the antibiotic-suppression group and 41.1% (95% CI = 34.9% to 48.5%) for the non-suppression group (hazard ratio [HR] = 0.63, p = 0.008). Stratification by the type of surgery and the infecting organism showed a higher five-year survival rate for the patients in the suppression group who underwent irrigation and debridement with polyethylene exchange (64.7%) compared with those in the non-suppression group who underwent irrigation and debridement with polyethylene exchange (30.4%, p < 0.0001) and a higher five-year survival rate for the patients in the suppression group who had a Staphylococcus aureus infection (57.4%) compared with those in the non-suppression group who had a Staphylococcus aureus infection (40.1%, p = 0.047).
CONCLUSIONS: Chronic suppression with oral antibiotics increased the infection-free prosthetic survival rate following surgical treatment for periprosthetic joint infection. Patients who underwent irrigation and debridement with polyethylene exchange and those who had a Staphylococcus aureus infection had the greatest benefit.
Copyright © 2015 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26246256     DOI: 10.2106/JBJS.N.00999

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  22 in total

1.  Does Change in ESR and CRP Guide the Timing of Two-stage Arthroplasty Reimplantation?

Authors:  Jeffrey B Stambough; Brian M Curtin; Susan M Odum; Michael B Cross; J Ryan Martin; Thomas K Fehring
Journal:  Clin Orthop Relat Res       Date:  2019-02       Impact factor: 4.176

Review 2.  Prosthetic Joint Infections: an Update.

Authors:  C L Abad; A Haleem
Journal:  Curr Infect Dis Rep       Date:  2018-05-22       Impact factor: 3.725

Review 3.  [Treatment of periprosthetic infections].

Authors:  L Renner; C Perka; A Trampuz; N Renz
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

4.  Prolonged suppressive antibiotic therapy is successful in the management of prosthetic joint infection.

Authors:  N A Sandiford; J R Hutt; D O Kendoff; P A Mitchell; M Citak; L Granger
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-10-01

5.  Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.

Authors:  V Prendki; T Ferry; P Sergent; E Oziol; E Forestier; T Fraisse; S Tounes; S Ansart; J Gaillat; S Bayle; O Ruyer; F Borlot; G Le Falher; B Simorre; F-A Dauchy; S Greffe; T Bauer; E N Bell; B Martha; M Martinot; M Froidure; M Buisson; A Waldner; X Lemaire; A Bosseray; M Maillet; V Charvet; A Barrelet; B Wyplosz; M Noaillon; E Denes; E Beretti; M Berlioz-Thibal; V Meyssonnier; E Fourniols; L Tliba; A Eden; M Jean; C Arvieux; K Guignery-Kadri; C Ronde-Oustau; Y Hansmann; A Belkacem; F Bouchand; G Gavazzi; F Herrmann; J Stirnemann; A Dinh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-04       Impact factor: 3.267

6.  Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patients.

Authors:  M Pradier; O Robineau; A Boucher; M Titecat; N Blondiaux; M Valette; C Loïez; E Beltrand; S Nguyen; H Dézeque; H Migaud; Eric Senneville
Journal:  Infection       Date:  2017-10-20       Impact factor: 3.553

Review 7.  Indications and Guidelines for Debridement and Implant Retention for Periprosthetic Hip and Knee Infection.

Authors:  Douglas A Zaruta; Bowen Qiu; Andrew Y Liu; Benjamin F Ricciardi
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

Review 8.  Risk Factors and Treatment Options for Failure of a Two-Stage Exchange.

Authors:  Lorenzo Fagotti; Jakub Tatka; Mauro Jose Costa Salles; Marcelo C Queiroz
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

9.  The Mark Coventry, MD, Award: Oral Antibiotics Reduce Reinfection After Two-Stage Exchange: A Multicenter, Randomized Controlled Trial.

Authors:  Jonathan M Frank; Erdan Kayupov; Mario Moric; John Segreti; Erik Hansen; Curtis Hartman; Kamil Okroj; Katherine Belden; Brian Roslund; Randi Silibovsky; Javad Parvizi; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2017-01       Impact factor: 4.176

10.  Benefits and Adverse Events Associated With Extended Antibiotic Use in Total Knee Arthroplasty Periprosthetic Joint Infection.

Authors:  Neel B Shah; Beverly L Hersh; Alex Kreger; Aatif Sayeed; Andrew G Bullock; Scott D Rothenberger; Brian Klatt; Brian Hamlin; Kenneth L Urish
Journal:  Clin Infect Dis       Date:  2020-02-03       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.